Results 151 to 160 of about 1,816 (169)

Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Journal of Medical Virology, 2016
Norio Akuta, Hitomi Sezaki, Tetsuya Hosaka   +2 more
exaly  

Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients

Journal of Gastroenterology and Hepatology (Australia), 2016
Jōji Toyota, Yoshiyasu Karino, Yoshiiku Kawakami   +2 more
exaly  

Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients

Journal of Gastroenterology and Hepatology (Australia), 2017
Kei Morio, Michio Imamura, Yoshiiku Kawakami   +2 more
exaly  

Characterization of ADME properties of [14C]asunaprevir (BMS-650032) in humans

Xenobiotica, 2016
Timothy Eley, Hao Jiang, John A Easter
exaly  

Asunaprevir: An HCV Protease Inhibitor With Preferential Liver Distribution

Clinical Pharmacology in Drug Development, 2017
Timothy Eley, Tushar Garimella
exaly  

Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection

Journal of Clinical Pharmacology, 2018
Mayu Osawa, Takayo Ueno, Yasuhiko Imai   +2 more
exaly  

Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2015
Hao Jiang, Hamza Kandoussi, Jianing Zeng   +2 more
exaly  

A highly sensitive and selective LC–MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studies

Journal of Pharmaceutical and Biomedical Analysis, 2016
Hamza Kandoussi, Hao Jiang, Jianing Zeng   +2 more
exaly  

Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older

Journal of Medical Virology, 2017
Norio Akuta, Tetsuya Hosaka
exaly  

A rugged and accurate liquid chromatography–tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2013
Long Yuan, Hao Jiang, Yuan-Qing Xia
exaly